Assessment of visible haematuria

Last reviewed: 13 Feb 2025
Last updated: 25 Jun 2024

Summary

Differentials

Common

  • Benign prostatic hyperplasia (BPH)
  • Urinary tract infection (UTI)
  • Acute pyelonephritis
  • Bladder cancer
  • Prostate cancer
  • Kidney stone
  • Instrumentation of the urinary tract
  • Menstruation
Full details

Uncommon

  • Renal trauma
  • Bladder trauma
  • Urethral trauma
  • Sickle cell anaemia
  • Coagulopathy
  • Cystic renal disease
  • Arteriovenous malformation
  • Renal vein thrombosis
  • Alport syndrome
  • Extrapulmonary tuberculosis
  • Benign familial haematuria (thin basement membrane nephropathy)
  • Post-infectious glomerulonephritis
  • Membranoproliferative glomerulonephritis
  • Rapidly progressive glomerulonephritis
  • IgA nephropathy
  • Systemic lupus erythematosus (SLE)
  • Renal cancer
  • Metastatic cancer
  • Urethral cancer
  • Penile cancer
  • Placenta percreta
  • Endometriosis
  • Bladder stone
  • Radiation cystitis
  • Nephrotoxic/cytotoxic medications
  • Anticoagulation
  • Exercise-induced haematuria
  • Loin pain haematuria syndrome
  • Medication
  • Food-related
Full details

Contributors

Authors

Simon Y. Kimm, MD
Simon Y. Kimm

Clinical Fellow and Instructor

Division of Urologic Oncology

Memorial Sloan-Kettering Cancer Center

New York

NY

Disclosures

SYK declares that he has no competing interests.

Jeffrey H. Reese, MD
Jeffrey H. Reese

Department of Urology

Santa Clara Valley Medical Center

San Jose

Clinical Professor of Urology

Stanford University School of Medicine

Stanford

CA

利益声明

JHR declares that he has no competing interests.

同行评议者

Lynda Frassetto, MD

Associate Professor of Medicine

Division of Nephrology

University of California at San Francisco

CA

利益声明

LF declares that she has no competing interests.

Michael Fischer, MD

Assistant Professor of Medicine

University of Illinois

Chicago College of Medicine

Department of Nephrology

Chicago

IL

利益声明

MF declares that he has no competing interests.

Junaid Masood, MBBS, FRCS (Eng), MSc (Urol), FRCS (Urol)

Consultant Urological Surgeon

Bart's and The London NHS Trust

London

UK

利益声明

JM declares that he has no competing interests.

Vinod Nargund, PhD, FRCS (Urol), FEBU

Consultant Urological Surgeon

Homerton University and Bartholomew's Hospitals

London

UK

利益声明

VN declares that he has no competing interests.

  • Assessment of visible haematuria images
  • 指南

    • Guidelines on urological trauma
    • Urotrauma guideline
    更多 指南
  • 患者教育信息

    Cystitis

    Enlarged prostate: what is it?

    更多 患者教育信息
  • Videos

    Venepuncture and phlebotomy animated demonstration

    更多 操作视频
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer